Zolimidine
![]() | |
![]() | |
Names | |
---|---|
Preferred IUPAC name 2-[4-(Methanesulfonyl)phenyl]imidazo[1,2-a]pyridine | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
ECHA InfoCard | 100.013.589 |
KEGG | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C14H12N2O2S | |
Molar mass | 272.32 g/mol |
Density | 1.31 g/cm3 |
Pharmacology | |
A02BX10 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Zolimidine (zoliridine, brand name Solimidin) is a gastroprotective[1] drug previously used for peptic ulcer[2] and gastroesophageal reflux disease.[3]
See also
[edit]References
[edit]- ^ Parisio, C; Clementi, F (November 1976). "Surface Alterations Induced by Stress in Gastric Mucosa: Protective Effect of Zolimidine. A Transmission and Scanning Electron Microscope Investigation". Laboratory Investigation. 35 (5): 484–95. PMID 136548.
- ^ Belohlavek, D; Malfertheiner, P (1979). "The Effect of Zolimidine, Imidazopyridine-derivate, on the Duodenal Ulcer Healing". Scandinavian Journal of Gastroenterology. Supplement. 54: 44. PMID 161649.
- ^ Materia, A; Basso, N; Bagarani, M; Basoli, A; Speranza, V (30 April 1981). "Treatment of Alkaline Reflux Gastritis with Zolimidine. Controlled Study". La Clinica Terapeutica. 97 (2): 183–91. PMID 6453678.